Nov 19, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Generate Biomedicines on a series of immunopeptidomics projects. On Nov 18 2021, Generate Biomedicines just announced a Series B financing of $370 million to advance its protein-targeted drug generation platform.
Nov 15, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Netherlands Cancer Institute on a series of quantitative phosphoproteomics projects.
Nov 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Patrick S. Moore and his team from University of Pittsburgh on a series of clinical proteomics projects focusing on leveraging our neoantigen quantification assays for biological discoveries.
October 1, 2021 | BALTIMORE – Complete Omics today announced that Benjamin Orsburn, PhD, has joined the Company’s Board of Advisors, effective Oct 1st, 2021. Dr. Orsburn joins the Complete Omics Board of Advisors with fruitful research and business experience in proteomics applications and his deep vision in latest developments of proteomics assays.
Sept 16, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Dianqing (Dan) Wu from Yale University on a series of quantitative proteomics focusing on leveraging our clinical quantitative proteomics assays for biological discoveries.
Aug 30, 2021 | BALTIMORE – Complete Omics’ Clinical Genomics team announced a collaboration with Professor Ching-shuen Wang from Taipei Medical University on a series of RNA-seq projects leveraging our DEEPER-SeqS clinical genomics assays for biological discoveries from hard-to-sequence clinical samples.
July 18, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yiping He from Duke University on a series of grants focusing on leveraging our labeling-dependent large scale quantitative proteomics assays for biological discoveries.
July 16th, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Prof. Dr. Roland Schüle from University Medical Center Freiburg, the teaching hospital of the University of Freiburg.
July 15, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Benjamin Vincent from The University of North Carolina, on neoantigen-related projects.
July 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Christian S. Hinrichs from Rutgers Cancer Institute of New Jersey.
Complete Omics — making OMICS-based clinical care a reality.
